Lung Cancer f

Embed Size (px)

Citation preview

  • 8/6/2019 Lung Cancer f.

    1/91

    LungCancer

  • 8/6/2019 Lung Cancer f.

    2/91

    INTRODUCTION

    Cancer is the term used for diseases in whichabnormal cells divide (mitosis) without control.Cancer cells can invade nearby tissues andspread through the bloodstream and lymphaticsystem to other parts of the body (metastasis) .Cancer cells also avoid natural cell death(apoptosis).

    The word originated from the Latin word forcrab, because the swollen veins around a surfacetumor appeared like the legs of a crab.

  • 8/6/2019 Lung Cancer f.

    3/91

  • 8/6/2019 Lung Cancer f.

    4/91

  • 8/6/2019 Lung Cancer f.

    5/91

    Right lung=3 lobes

    Left lung=2 lobes

    Air enters lungsthrough trachea

    Trachea divides intobronchi

    Bronchi divide intobronchioles

    Alveoli are the air sacsat the end of thebronchioles

    Pleura = lining of the

    lungs

    ANATOMY OF LUNGS

  • 8/6/2019 Lung Cancer f.

    6/91

    FUNCTIONS OF LUNGS

    Every day one human being takes about 23,000 breaths,which bring almost 10,000 quarts of air into your lungs.

    The air that breath in contains several gases, includingoxygen, that cells need to function.

    With each breath, lungs add fresh oxygen to blood,which then carries it to cells. The lungs are the

    essential respiration organ in humans.

    Their principal function is to transport oxygen from theatmosphere into the bloodstream, and to release carbondioxide from the bloodstream into the atmosphere.

  • 8/6/2019 Lung Cancer f.

    7/91

    Seven cardinal signs of cancer

    C Change in bowel or bladderhabits could be a sign ofcolorectal cancer.

    A sore that does not heal onthe skin or in the mouth could bea malignancy and should bechecked by a doctor.

    U Unusual bleeding or dischargefrom the rectum, bladder orvagina could mean colorectal,

    prostate, bladder or cervicalcancer.

  • 8/6/2019 Lung Cancer f.

    8/91

  • 8/6/2019 Lung Cancer f.

    9/91

    CONTDO Obvious changes to molesor warts could mean skincancer.

    N Nagging cough orhoarseness that persists forfour to six weeks could be a

    sign of lung or throat cancer.

  • 8/6/2019 Lung Cancer f.

    10/91

    Lung Cancer: Defined

    Uncontrolled growth of malignant cells inone or both lungs and tracheo-bronchialtree

    A result of repeated carcinogenicirritation causing increased rates of cellreplication

    Proliferation of abnormal cells leads tohyperplasia, dysplasia or carcinoma in

    situ

  • 8/6/2019 Lung Cancer f.

    11/91

    Picture of the CancerousLungs

  • 8/6/2019 Lung Cancer f.

    12/91

  • 8/6/2019 Lung Cancer f.

    13/91

    Most frequently diagnosed cancer

    worldwide About 1.35 million new cases diagnosed

    worldwide each year

    Leading cause of cancer deaths inthe United States

  • 8/6/2019 Lung Cancer f.

    14/91

    Incidence andmortality ratesbegin to increasebetween the agesof 45 and 54 andrise progressivelyuntil age 75

    Median age atdiagnosis=70.07

    Median age atdeath=71.07

  • 8/6/2019 Lung Cancer f.

    15/91

    Males have a greater lifetime risk oflung cancer than females (7.81% vs.

    5.8%)

    Greater disparity in developing countrieswhere cigarette use by females is low

  • 8/6/2019 Lung Cancer f.

    16/91

    Higher incidence and mortality ratesare reported among men from lower

    SES groups

  • 8/6/2019 Lung Cancer f.

    17/91

    Cigarette smoking is the most importantrisk factor for lung cancer

    Causes approximately 90% of male and 75-80% of female lung cancer deaths

    By the early 1950s, case control studiesin the US and Great Britain clearlyshowed an association between smokingand lung cancer

    In 1964, the US Surgeon Generalreleased a report on the causal

    relationship

  • 8/6/2019 Lung Cancer f.

    18/91

    Smoking Facts

    Tobacco use is theleading cause of lungcancer

    87% of lung cancersare related to smoking

    Risk related to:

    age of smoking onset

    amount smoked gender

    product smoked

    depth of inhalation

  • 8/6/2019 Lung Cancer f.

    19/91

    More than 80carcinogens in cigarettesmoke according to theInternational Agencyfor Research on Cancer(IARC)

    Polycyclic aromatic

    hydrocarbons (PA

    Hs) area well documented lungcarcinogen

  • 8/6/2019 Lung Cancer f.

    20/91

    Secondhand smoke

    Each year about 3,000 non-smoking

    adults die of lung cancer as a result ofbreathing secondhand smoke.

  • 8/6/2019 Lung Cancer f.

    21/91

    Whatabout

    secondhand smoke?

    Being in a nonsmoking section of arestaurant for 2 hours =

    Being in a smoky home for one day =

    Being in a smoky bar =

    Mayo Clinic

  • 8/6/2019 Lung Cancer f.

    22/91

    History of respiratory diseases such asasthma, bronchitis, emphysema, hayfever, or pneumonia may modify risk

    When combined with smoking, there is acomplementary cycle of injury and repairthat may increase risk

    Respiratory diseases may result in

    chronic immune stimulation that causesrandom pro-oncogenic mutations thatincrease risk

    Relationship is still speculative

  • 8/6/2019 Lung Cancer f.

    23/91

    Animal models have indicated that dietaryfat can promote chemically induced

    pulmonary tumors. Relationship may be confounded by the

    association between smoking status and diet

    Rates of lung cancer are highest incountries with greatest fat consumptionafter controlling for smoking.

  • 8/6/2019 Lung Cancer f.

    24/91

    Lowered risk associated with consumptionof fresh vegetables and fruits Risk in those with highest intake was about

    one-half of those with lowest intake

    Beneficial micronutrients in fruits andvegetables Carotenoids Isothiocyanates Folate Selenium

  • 8/6/2019 Lung Cancer f.

    25/91

    Difficult to assess association betweenalcohol and lung cancer due to

    confounding by smoking status

  • 8/6/2019 Lung Cancer f.

    26/91

    IARC categorized several occupational

    agents as known carcinogens Radon

    x Well established lung carcinogen, responsible for 6.5%of lung cancer deaths in the United Kingdom in 1998

    Asbestos

    Arsenic

    Bischloromthyl ether

    Chromium Nickel

    Polycyclic aromatic compounds

    Vinyl chloride

  • 8/6/2019 Lung Cancer f.

    27/91

    Only a fraction of long-term smokers willdevelop lung cancer

    Likely impacted by genetic susceptibility Familial aggregation

    Studies have reported an excess of lung cancermortality in relatives of lung cancer patients

  • 8/6/2019 Lung Cancer f.

    28/91

    Polymorphisms in genes encoding forenzymes responsible for detoxification of

    carcinogens affect the internal dose oftobacco carcinogens that lung tissue isexposed to

    Many different polymorphisms

    Cytochrome P-450

  • 8/6/2019 Lung Cancer f.

    29/91

    Defective repair of genetic damage is animportant determinant of susceptibility to

    lung cancer Hypersensitivity to carcinogenic exposure

    Many studies have demonstrated that cancercases have a significant decrease in DNA

    repair capacity compared to controls

  • 8/6/2019 Lung Cancer f.

    30/91

    Where does it travel?

    Lymph Nodes, Brain, Liver, Adrenal,Gland, Bones

    40% of metastasis occurs in the

    Adrenal Gland

  • 8/6/2019 Lung Cancer f.

    31/91

    PATHOPHYSIOLOGYMore than 90% of lung cancer originate

    from the epithelium of bronchus. Theyslowly & it takes 8 to 10 years, for atumor to reach 1cm in size.

    Cancerous lung tissue cannot exchangeoxygen & carbon dioxide

    It impairs the functioning of the lung

  • 8/6/2019 Lung Cancer f.

    32/91

    Tumor cells grow & invade

    surrounding lung tissue

    Air way invaded & obstructing the

    flow of the air

    Cancerous cells invade local lymph

    nodes & thoracic duct

    Significant growth of the tumor

  • 8/6/2019 Lung Cancer f.

    33/91

    Evolution of Intraepithelial Neoplasia

    Mild/Moderate/Severe/CIS

    Squamous

    Adenomatous

    Normal Hyperplasia/Metaplasia Dysplasia Cancer

  • 8/6/2019 Lung Cancer f.

    34/91

    Types:

    There are 4 major types :Non- small cell carcinoma:-

    1- epidermiod [squamous] -35%

    2- adeno carinema -30%

    3- large cell carcinoma -15%

    4- small cell lung cancer -20%

  • 8/6/2019 Lung Cancer f.

    35/91

    Epidermiod carcinoma -35% :

    Occurs most frequently in men and oldpeople

    Usually starts on one breathing tubes. Tend to be localized in the chest longer

    than other types of lung cancer.

    Does not tend to metastasize early.

    It is strongly associated with smoking.

  • 8/6/2019 Lung Cancer f.

    36/91

    Adenocarcinnoma-30%:

    Most common cancer amongwomen.

    Usually started near the outer

    edges of the lung. Invasion of pleura and

    mediastinal lymph node is

    common. May spread to other parts of thebody.

    Can be seen in non smoker.

  • 8/6/2019 Lung Cancer f.

    37/91

    Large cell carcinoma 15% :

    Less well differentiated. May occur at any part of the

    lung.

    Tumors are large by the timethey are diagnosed.

    Has greater possibility ofspreading to brain andmediastinum.

  • 8/6/2019 Lung Cancer f.

    38/91

    Small cell lung cancer:

    Small cell lung cancer also called oatcellbecause SCLC cells have oat grainappearance.

    It arises from endocrine cells[kulchitisky cells] where many hormonesare secreted

    Spread to lymph nodes and other organsmore quickly than NSCLC .

  • 8/6/2019 Lung Cancer f.

    39/91

    Cntd.

    Usually started in one larger breathing tube.

    .Tend to grow rapidly .

    Commonly has spread by the time and is

    considered a systemic disease.

    It is the only one of the bronchialcarcinomas that respond to chemotherapy

  • 8/6/2019 Lung Cancer f.

    40/91

    NON SMALL CELL LUNG

    CANCERIt is staged according to the sizeof the tumor, the level of lymphnode involvement and the extent

    to which the cancer has spread.The stages include:STAGE 0:Cancer is limited to

    the lining of the air passage andhasnt invaded lung tissue.STAGE1:Invaded to lung tissue

    Hasnt invaded to lymph nodes

  • 8/6/2019 Lung Cancer f.

    41/91

    CONTD

    STAGEII: Spread to neighboringlymph nodes Invaded the chest wall

    STAGEIIIA: Spread from the lung tolymph nodes.

    STAGEIII B: Spread locally to areas .

    STAGEIV :spread to other parts ofthe body.

    NSCLC S i

  • 8/6/2019 Lung Cancer f.

    42/91

    NSCLC StagingT 1: tumor < 3 cm

    T2: tumor > 3 cm, >2 cm from carina, invading the

    pleura, partial lung collapseT3:

  • 8/6/2019 Lung Cancer f.

    43/91

    SCLC Limited StageDefined as tumor involvement of one lung,the mediastinum and ipsilateral and/orcontralateral supraclavicular lymph nodes

    or disease that can be encompassed in asingle radiotherapy port.

    Extensive Stage

    Defined as tumor that has spread beyondone lung, mediastinum, and supraclavicularlymph nodes. Common distant sites ofmetastases are the adrenals, bone, liver,bone marrow, and brain.

  • 8/6/2019 Lung Cancer f.

    44/91

    Presentations:

    Lung cancer may present innumber of different ways :

    Most commonly symptomsreflect local involvement of thebronchus.

    May also arise from spread to

    the chest wall or mediastinum orfrom distant blood-bornespread.

  • 8/6/2019 Lung Cancer f.

    45/91

    Local effects of tumor withinthe bronchus :

    1- cough ( in 80% of cases ) :

    - It is the most common early symptoms.

    - sputum is purulant if there is secondaryinfection.

    - A change in the character of the (regular

    cough) associated with other newrespiratory symptoms increase thepossibilityof B.C.

  • 8/6/2019 Lung Cancer f.

    46/91

    2-Haemoptysis (in 70% of cases):

    - Repeated episodes of scanty

    cough hemoptysis or blood streaking of sputum in smokersare highly suggestive of B.C and

    should be always investigated .

  • 8/6/2019 Lung Cancer f.

    47/91

    Cntd.

    3- Dyspnea ( 60% of cases ):- reflect occulusion of a largebronchus resulting in collapse of a

    lobe of the lung or development ofplearal effusion.4- Pleural pain :- reflect malignant invasion of thepleura or reflect infection distalto a tumuor (wich is recurrentand fail to resolve).

  • 8/6/2019 Lung Cancer f.

    48/91

    Direct spread:

    Involvement of pleura and ribs .

    -Pancoasts tumour: involvement of lower

    part of the brachial plexus ( C8 , T1,T2)causing severe pain of the shoulder anddown inner surface of the arm.

    -Horner syndrom: due to involvement of the

    sympathetic ganglion.

  • 8/6/2019 Lung Cancer f.

    49/91

    Contd.

    -Recurrent laryngeal nerve palsy :causing unilateral vocal cord paresiswith hoarsness of voice and a bovine

    cough..Invation of phrenic nerve ,

    causing paralysis of thediaghragm.

  • 8/6/2019 Lung Cancer f.

    50/91

    .Involvement of esophagus ,causing dysphagia.

    .Cardiovascular: atrial fibrillation,temponade ,pericarditis,pericardial effusion .

  • 8/6/2019 Lung Cancer f.

    51/91

    Contd..

    . Superior vena cava obstructioncausing early morning headache,facial congestion and edema

    involving the upper limb,distention of jugular vein andveins of the chest.

  • 8/6/2019 Lung Cancer f.

    52/91

    Nonmetastatic extrapulmonary manifistation:1- Endocrine manifestation:12% of tumors ,in particular small

    cell tumors present withSIADH, ACTH secretion(SCLC),hypercalcemia (sq.cellcarcinoma),bone metastasis

    gynaecomastia(LCLC) .

  • 8/6/2019 Lung Cancer f.

    53/91

    Contd.

    2- Neurological manifetation:e.g: sensory polyneuropathy

    ,myelopathy, cerebellardegeneration.

  • 8/6/2019 Lung Cancer f.

    54/91

    Cntd.

    3- Others: Digital clubbing ,

    Hypertrophic pulmenary osteo-

    arthropathy (sq.cell cancer) , Nephrotic syndrome,

    Hypercoagulopathy (adenocarcinoma),

    Thrombophelibitis migricans.

  • 8/6/2019 Lung Cancer f.

    55/91

    Blood borne metastasis:

    .Bony metastasis giving severe bony painand pathalogical fractures.

    .liver metastasis (Jundice)

    .Brain metastasis (change in personality,epilpsy,focal neurological symptoms).

  • 8/6/2019 Lung Cancer f.

    56/91

    DIAGNOSTIC STUDIES

  • 8/6/2019 Lung Cancer f.

    57/91

    Physical signs:

    Examination is usually normalunless there is significantbronchial obstruction or tumor

    has spread to pleura ormediastinum.

  • 8/6/2019 Lung Cancer f.

    58/91

    Cntd.

    1- physical signs of collapse (in largeobstructing tumor) which may rise topneumonia.

    2- monophonic or unilateral wheeze (fixedbronchial obstruction).

    3- stridor (obstruction at or above thelevel of main carina.

  • 8/6/2019 Lung Cancer f.

    59/91

    Contd..

    4- hoarsness of voice associated withbovine cough (recurrent laryngeal nervepalsy).

    5- dullness percussion and absent breathsounds at the lung base (unilateraldiaphragmatic palsy due to involvement

    of phrenic nerve)

  • 8/6/2019 Lung Cancer f.

    60/91

    Contd.

    6- physical signs of pleursy or pleuraleffusion (involvement of pleura).

    7- bilateral engorgement of the jangularvein and later edema affecting face,neck, arms.

    8- tenderness and pain of long bone andjoints .

  • 8/6/2019 Lung Cancer f.

    61/91

    Investigation:

    Sputum cytology: high yield for

    endobronchial tumors such assquamous cell and small cellcarcinoma.

  • 8/6/2019 Lung Cancer f.

    62/91

    chest x-ray:common radiologicalpresentation of bronchialcarcinoma.

    1- unilateral hilar-enlagement.

    2- peripheral pulmonary opacity.3- lung, lobe or segmental

    collapse.

  • 8/6/2019 Lung Cancer f.

    63/91

    . Bronchoscopy : gives high yield inexcess of 90% (allows biopsy andbronchial brush samples) if fail

    precautious fine needle aspiration underCT.

  • 8/6/2019 Lung Cancer f.

    64/91

    .CT thorax and upper abdomen.

    .Head CT scan.

    .Radio nuclide bone scanning.

    .liver US.

    .bone marrow biopsy.

  • 8/6/2019 Lung Cancer f.

    65/91

    MANAGEMENT

  • 8/6/2019 Lung Cancer f.

    66/91

    MANAGEMENT

    Medical management :1. Radiation therapy

    2. Chemotherapy

    3. Bronchoscopic laser therapy

    4. Photodynamic therapy

    5. Airway stentingSurgical management :

    1. Surgical resection

    RADIATION THERAPY

  • 8/6/2019 Lung Cancer f.

    67/91

    RADIATION THERAPY Radiation therapy uses high-energy radiation

    to shrink tumors and kill cancer cells . X-rays, gamma rays, and charged particles aretypes of radiation used for cancertreatment.

    The radiation may be delivered by a machineoutside the body (external-beam radiationtherapy), or it may come from radioactivematerial placed in the body near cancer cells

    (internal radiation therapy, also calledbrachytherapy).

    About half of all cancer patients receivesome type of radiation therapy sometime

    during the course of their treatment.

    H d d h

  • 8/6/2019 Lung Cancer f.

    68/91

    How does radiation therapykill cancer cells?

    Radiation therapy kills cancer cells bydamaging their DNA (the molecules inside cellsthat carry genetic information and pass itfrom one generation to the next) .

    Radiation therapy can either damage DNAdirectly or create charged particles (freeradicals) within the cells that can in turndamage the DNA.

    Cancer cells whose DNA is damaged beyondrepair stop dividing or die. When the damagedcells die, they are broken down and eliminatedby the bodys natural processes.

    Linear Accelerator Used for

  • 8/6/2019 Lung Cancer f.

    69/91

    Linear Accelerator Used forExternal-beam Radiation

    Therapy

    SIDE EFFECTS OF

  • 8/6/2019 Lung Cancer f.

    70/91

    SIDEEFFECTS OFRADIATION THERAPY

    Acute side effects of radiation therapyare:-

    Cough

    Pharyngitis

    Esophagitis

    Anorexia

    Weight loss

    Fatigue

    Skin reactions

    CONTD

  • 8/6/2019 Lung Cancer f.

    71/91

    CONTD. Late side effects of radiation therapy

    may or may not occur. Depending on thearea of the body treated, late sideeffects can include :

    Fibrosis (the replacement of normal tissue

    with scar tissue, leading to restrictedmovement of the affected area).

    Damage to the bowels, causing diarrhea andbleeding.

    Memory loss. Infertility (inability to have a child).

    DRUG AMINOFOSTINE IS GIVEN TOLESSEN THE SIDEEFFECTS OF

    RADIATION THERAPY.

    CHEMOTHERAPY

  • 8/6/2019 Lung Cancer f.

    72/91

    CHEMOTHERAPY Chemotherapy (also called chemo) is a

    type of cancer treatment that uses drugsto destroy cancer cells.

    Chemotherapy works by stopping orslowing the growth of cancer cells, which

    grow and divide quickly. But it can also harm healthy cells that

    divide quickly, such as those that line yourmouth and intestines or cause your hair to

    grow. Damage to healthy cells may cause side

    effects. Often, side effects get better

    or go away after chemotherapy is over.

    DRUGS USED FOR

  • 8/6/2019 Lung Cancer f.

    73/91

    DRUGS USED FORCHEMOTHERAPY

    Cisplantin

    Vincristine

    Palcitaxel

    Cyclophosphamide

    Doxorubicin

    SIDE EFFECTS OF CHEMOTHERAPY

  • 8/6/2019 Lung Cancer f.

    74/91

    SIDEEFFECTS OFCHEMOTHERAPY

    NephrotoxicityNausea

    Vomiting

    MyelosupressionPulmonary toxicity

  • 8/6/2019 Lung Cancer f.

    75/91

    PHOTODYNAMIC THERAPY

    Photodynamic therapy (PDT) is atreatment that uses a drug, called aphotosensitizer or photosensitizingagent, and a particular type of light.

    When photosensitizers are exposed to aspecific wavelength of light, they

    produce a form of oxygen that killsnearby cells.

    How is PDT used to treat

  • 8/6/2019 Lung Cancer f.

    76/91

    How is PDT used to treatcancer?

    In the first step of PDT for cancer treatment,a photosensitizing agent is injected into thebloodstream.

    The agent is absorbed by cells all over the body

    but stays in cancer cells longer than it does innormal cells.

    Approximately 24 to 72 hours after injection,when most of the agent has left normal cells

    but remains in cancer cells, the tumor isexposed to light.

    The photosensitizer in the tumor absorbs thelight and produces an active form of oxygenthat destroys nearby cancer cells.

  • 8/6/2019 Lung Cancer f.

    77/91

    AIRWAY STUNT

  • 8/6/2019 Lung Cancer f.

    78/91

    Surgery

  • 8/6/2019 Lung Cancer f.

    79/91

    NURSING MANAGEMENT

  • 8/6/2019 Lung Cancer f.

    80/91

    NSG ASSESSMENT

    Determine the understanding ofpatient & the family concerning thediagnostic tests.

    Assess the level of anxiety. Determine onset & duration of

    coughing, sputum production, &degree of dyspnea.

  • 8/6/2019 Lung Cancer f.

    81/91

    CONTD Auscultate for breath

    sounds.

    Observe symmetry of chestduring respiration.

    Ask about pain, its location,

    intensity & factorsinfluencing pain.

  • 8/6/2019 Lung Cancer f.

    82/91

    NSG DIAGNOSES Ineffective breathing pattern

    related to obstructiverespiratory processes

    associated with lung cancer

    Imbalanced nutrition: less than

    body requirements related tohyper metabolic state, tasteaversion, anorexia

  • 8/6/2019 Lung Cancer f.

    83/91

    CONTD Acute or chronic pain related to

    tumor effects, invasion ofadjacent structures, toxicities

    associated with radiotherapy/chemotherapy

    Anxiety related to uncertain

    outcomes & fear recurrence

    NSG INTERVENTIONS

  • 8/6/2019 Lung Cancer f.

    84/91

    NSG INTERVENTIONS

    Improving breathingpatterns Elevate head of bed to promote

    gravity drainage.

    Teach breathing retrainingexercises.

    Give prescribed treatment such as

    antimicrobial agents. Augment the patients ability to

    cough.

  • 8/6/2019 Lung Cancer f.

    85/91

    CONTD Adminster oxygen if prescribed. Allow patient to sleep in reclining

    chair or with head of bed elevated

    if severely dyspneic.Improvingnutritionalstatus :

    Encourage small amounts of highcalroie & high protein foods.

    Ensure adequate protein intake :milk, eggs, chicken, fish, cheese etc.

    CONTD

  • 8/6/2019 Lung Cancer f.

    86/91

    CONTD Adminster or encourage prescribed

    vitamin supplement . Change consistency of diet to soft or

    liquid.

    Give enteral or total parenteralnutrition for malnourished patientswho is unable to eat.

    Controlling pain :

    Assess condition of the patient.

    Give analgesics to the patient.

  • 8/6/2019 Lung Cancer f.

    87/91

    CONTD Evaluate problems of insomnia,

    depression, anxiety etc.

    Initiate bowel training program.

    Minimizinganxiety : Try to have the patient exress

    concerns ; share these concerns.

    Expect some feelings of anxiety.

    Encourage the patient to

    communicate feelings.

    HEALTH EDUCATION

  • 8/6/2019 Lung Cancer f.

    88/91

    HEALTH EDUCATION

    QUIT SMOKING,

    IF PATIENTQUIT SMOKINGTHEN

  • 8/6/2019 Lung Cancer f.

    89/91

    HEALTH EDUCATION

  • 8/6/2019 Lung Cancer f.

    90/91

    HEALTH EDUCATION Help the patient Teach the

    patient to to realize that everypain & ache is caused by lungcancer.

    Take NSAIDS or otherprescribed medication.

    Tell the patient abouttreatment.

    Advise the patient to report

    new or persistent pain.

  • 8/6/2019 Lung Cancer f.

    91/91